Approved Use: TAVNEOS® is a prescription medicine that is used with other medicines (such as glucocorticoids) to treat adults with severe
Read moreApproved Use: TAVNEOS® is a prescription medicine that is used with other medicines (such as glucocorticoids) to treat adults with severe active anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (granulomatosis with polyangiitis [GPA], formerly known as Wegener’s granulomatosis, and microscopic polyangiitis [MPA]). It is not known if TAVNEOS is safe and effective in children under the age of 18.
Read lessThe link you have selected will take you away from the TAVNEOS® (avacopan) website to one that is not owned or controlled by ChemoCentryx. ChemoCentryx accepts no responsibility for the content of linked sites.
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click “OK” if you are a healthcare professional.
Based on your location, you are being redirected to the website of our licensee Vifor Fresenius Medical Care Renal Pharma Ltd. CCXI does not have responsibility for, or control of, the contents, availability, operation, or performance of the website.
These diseases involve inflammation of the blood vessels, which reduces blood flow and could lead to impaired organ function. While your genetics and environment are thought to be contributing causes of these diseases, the exact cause isn’t known yet.
Active disease means that you have signs and/or symptoms of the disease that are new, not getting better, or getting worse.
Severe disease is defined as AAV with signs and/or symptoms that are organ- or life-threatening.
Severe active GPA and MPA are serious but treatable diseases. Your doctor will work with you to develop a treatment plan that suits your needs.
GPA happens when immune cells clump together, forming what are known as granulomas. This causes inflammation in the blood vessels. It can affect the whole body, but often affects the kidneys, lungs, sinuses, nose, ears, and throat.
MPA shares many symptoms with GPA, but can have a more severe impact on the kidneys. People with MPA may be at a higher risk of uncontrolled bleeding in their lungs.
Identifying the signs and symptoms of severe active GPA or MPA early can lead to a timely diagnosis that can help you and your doctor decide on a treatment plan to help manage your condition.
Remission | Absence of GPA or MPA symptoms |
---|---|
Relapse | When GPA or MPA symptoms return after being previously controlled |
Severe active GPA and MPA are long-term, progressive diseases. There may be times when symptoms appear to worsen, as well as other times when they seem to be improving. Although there is no cure, there are treatments that can help patients achieve remission.
Even with treatment, some patients may continue to have symptoms. They may benefit from an update to their treatment plan. If you are having any symptoms that you think may be severe active GPA or MPA, be sure to talk to your doctor right away.
For treatment, your doctor may prescribe steroids known as glucocorticoids, such as prednisone, as well as other immunosuppressants to help control disease activity.
Glucocorticoids can be effective, but they can also cause a number of side effects. In fact, a lot of the side effects are often directly related to how long a patient is treated with glucocorticoids. For this reason, doctors have started to move toward treatments that can reduce exposure to high-dose glucocorticoids.
One way to help people achieve remission and reduce the dose of glucocorticoids is by using other immunosuppressants. Immunosuppressants are medications that target inflammation by lowering the activity of the body’s immune system. These medications have become part of the standard treatment for severe active GPA and MPA.
It can be tough managing your severe active GPA or MPA, but there are steps you can take to stay organized and take care of your condition. This may include requests from your doctor, as well as working to manage GPA or MPA between visits.
You may need to adjust your daily routine to manage your symptoms, and that’s okay! Work with your doctor to find the best way to manage them.
TAVNEOS® works differently than other immunosuppressants. Once added to your current treatment, TAVNEOS® is specifically designed to block a receptor involved in GPA and MPA, helping to reduce inflammation. The exact way in which TAVNEOS® works in severe active GPA and MPA isn’t completely understood.
TAVNEOS can cause serious side effects, including:
Your healthcare provider will do blood tests to check how well your liver is working before starting and during your treatment with TAVNEOS.
The most common side effects of TAVNEOS include:
TAVNEOS is a prescription medicine that is used with other medicines (such as glucocorticoids) to treat adults with severe active anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (granulomatosis with polyangiitis [GPA], formerly known as Wegener’s granulomatosis, and microscopic polyangiitis [MPA]).
These are not all the possible side effects of TAVNEOS. Call your doctor for medical advice about side effects. Please see the Full Prescribing Information and Medication Guide for further details.
TAVNEOS is available as a 10 mg capsule.
You are encouraged to report negative side effects to Amgen at 1-833-828-6367 or to the FDA by
visiting www.fda.gov/medwatch or calling 1-800-332-1088.
IMPORTANT SAFETY INFORMATION What is the most important information I should know about TAVNEOS? TAVNEOS can cause serious side effects, including: Liver problems. People taking TAVNEOS may have serious liver problems. Call your healthcare provider right away if you have unexplained symptoms such as: